Osborn H H, Zisfein J, Sparano R
Ann Emerg Med. 1987 Apr;16(4):407-12. doi: 10.1016/s0196-0644(87)80360-8.
A single 18 mg/kg dose of oral phenytoin capsules or suspension (mean dose, 1.3 g) was given to 44 patients with recent seizures and no detectable serum phenytoin level. Mean serum phenytoin levels after loading for patients receiving capsules were 6.8 micrograms/mL at two hours, 9.7 micrograms/mL at three to five hours, 12.3 micrograms/mL at six to ten hours, and 15.1 micrograms/mL at 16 to 24 hours. Mean levels for patients receiving suspension were slightly, but not significantly, lower than for patients receiving capsules. No seizures occurred during an eight-hour observation period after loading. Drug toxicity was minimal. Single-dose, 18 mg/kg oral phenytoin loading provides rapid therapeutic levels and is well tolerated.
对44例近期有癫痫发作且血清苯妥英水平检测不到的患者,给予单次口服18mg/kg剂量的苯妥英胶囊或混悬液(平均剂量1.3g)。接受胶囊治疗的患者负荷给药后2小时血清苯妥英平均水平为6.8微克/毫升,3至5小时为9.7微克/毫升,6至10小时为12.3微克/毫升,16至24小时为15.1微克/毫升。接受混悬液治疗的患者平均水平略低于接受胶囊治疗的患者,但差异无统计学意义。负荷给药后8小时观察期内未发生癫痫发作。药物毒性极小。单剂量18mg/kg口服苯妥英负荷给药可迅速达到治疗水平且耐受性良好。